Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey Quon

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Clinical Genitourinary Cancer|February 27, 2014
Population-based referrals for adjuvant radiotherapy after radical prostatectomy in men with prostate cancer: impact of randomized trialsHarvey Quon, Derek Suderman, Kimi Guilbert, et al.
The Canadian Journal of Urology|April 20, 2012
Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapyPerakaa Sethukavalan, Patrick Cheung, Colin I Tang, et al.
BMC Urology|October 24, 2014
The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysisJasmir G Nayak, Darrel E Drachenberg, Elke Mau, et al.
The Laryngoscope|March 5, 2022
Comparing the M.D. Anderson Symptom and Dysphagia Inventories for Head and Neck Cancer PatientsAdam H Yarschenko, Demetra H Yannitsos, Sarah Weppler, et al.
Cureus|November 10, 2017
Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder CancerAndrew Kochan, Ryan Rivest, Katie Galloway, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2020
Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19Kevin Martell, Philip McGeachy, Harvey Quon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2016
Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trialsH Bindu Musunuru, Harvey Quon, Melanie Davidson, et al.
Clinical and Translational Radiation Oncology|July 26, 2021
Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinomaRutvij A Khanolkar, Harvey Quon, Kundan Thind, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2023
Estimated absolute percentage of biopsied tissue positive for Gleason pattern 4 (eAPP4) in low dose rate prostate brachytherapy: Evaluation of prognostic utility in a large cohortGeoffrey Casey, Harvey Quon, Tyler Meyer, et al.
Frontiers in Oncology|June 24, 2021
Determining Clinical Patient Selection Guidelines for Head and Neck Adaptive Radiation Therapy Using Random Forest Modelling and a Novel Simplification HeuristicSarah Weppler, Harvey Quon, Colleen Schinkel, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical Genitourinary Cancer|February 27, 2014
Population-based referrals for adjuvant radiotherapy after radical prostatectomy in men with prostate cancer: impact of randomized trialsHarvey Quon, Derek Suderman, Kimi Guilbert, et al.
The Canadian Journal of Urology|April 20, 2012
Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapyPerakaa Sethukavalan, Patrick Cheung, Colin I Tang, et al.
BMC Urology|October 24, 2014
The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysisJasmir G Nayak, Darrel E Drachenberg, Elke Mau, et al.
The Laryngoscope|March 5, 2022
Comparing the M.D. Anderson Symptom and Dysphagia Inventories for Head and Neck Cancer PatientsAdam H Yarschenko, Demetra H Yannitsos, Sarah Weppler, et al.
Cureus|November 10, 2017
Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder CancerAndrew Kochan, Ryan Rivest, Katie Galloway, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2020
Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19Kevin Martell, Philip McGeachy, Harvey Quon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2016
Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trialsH Bindu Musunuru, Harvey Quon, Melanie Davidson, et al.
Clinical and Translational Radiation Oncology|July 26, 2021
Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinomaRutvij A Khanolkar, Harvey Quon, Kundan Thind, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2023
Estimated absolute percentage of biopsied tissue positive for Gleason pattern 4 (eAPP4) in low dose rate prostate brachytherapy: Evaluation of prognostic utility in a large cohortGeoffrey Casey, Harvey Quon, Tyler Meyer, et al.
Frontiers in Oncology|June 24, 2021
Determining Clinical Patient Selection Guidelines for Head and Neck Adaptive Radiation Therapy Using Random Forest Modelling and a Novel Simplification HeuristicSarah Weppler, Harvey Quon, Colleen Schinkel, et al.
Pageof 5